Skip to main content

Biosearch Licenses IP to DuPont for Food Dx Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DuPont Qualicon will have access to Biosearch Technologies' BHQ, CAL Fluor, and Quasar patents under a licensing agreement announced today.

As part of the deal, Biosearch will also manufacture Scorpions primer oligonucleotides for use in food diagnostics by DuPont. This past summer, Biosearch signed an agreement with Qiagen, expanding its rights to the Scorpions primer technology.

Financial terms of the alliance with DuPont were not disclosed.

Biosearch last week entered into a licensing deal with Seegene also covering the BHQ, CAL Fluor, and Quasar technologies.

In a statement announcing today's deal, Marc Beal, director of corporate development for Biosearch, said that it and DuPont's capabilities would deliver "an innovative and exacting molecular diagnostics solution," and added that the company looks forward to working with DuPont as it commercializes BHQ Scorpions-based foodborne pathogen diagnostics.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.